• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease.

作者信息

Hess Georg, Wagner Volker, Kreft Andreas, Heussel Claus Peter, Huber Christoph

出版信息

Br J Haematol. 2006 Sep;134(5):544-5. doi: 10.1111/j.1365-2141.2006.06212.x.

DOI:10.1111/j.1365-2141.2006.06212.x
PMID:16856889
Abstract
摘要

相似文献

1
Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease.硼替佐米对一名多中心Castleman病患者促炎细胞因子水平及输血依赖性的影响。
Br J Haematol. 2006 Sep;134(5):544-5. doi: 10.1111/j.1365-2141.2006.06212.x.
2
Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).硼替佐米对与POEMS综合征相关的多中心Castleman病难治型（MCD-POEMS变异型）的疗效。
Ann Hematol. 2010 Feb;89(2):217-9. doi: 10.1007/s00277-009-0795-6. Epub 2009 Jul 28.
3
Acute humoral rejection in a lung recipient: reversion with bortezomib.肺移植受者的急性体液排斥反应：硼替佐米治疗后逆转
Transplantation. 2010 Jan 15;89(1):125-6. doi: 10.1097/TP.0b013e3181c280f9.
4
Response to bortezomib in refractory type I cryoglobulinemia.硼替佐米对难治性Ⅰ型冷球蛋白血症的疗效
Am J Hematol. 2008 Nov;83(11):883-4. doi: 10.1002/ajh.21258.
5
Bortezomib in lung transplantation: a promising start.硼替佐米在肺移植中的应用：一个有前景的开端。
Clin Transpl. 2009:421-4.
6
Bortezomib in the treatment of antibody-mediated rejection--a report of 3 cases.硼替佐米治疗抗体介导的排斥反应——3例报告
Clin Transpl. 2009:361-8.
7
[Use of proteasome inhibitors in the treatment of patients with multiple myeloma].蛋白酶体抑制剂在多发性骨髓瘤患者治疗中的应用
Ter Arkh. 2006;78(10):40-4.
8
Bortezomib for refractory antibody-mediated cardiac allograft rejection.硼替佐米用于难治性抗体介导的心脏同种异体移植排斥反应。
Clin Transpl. 2009:475-8.
9
Bortezomib effectiveness in one patient with acquired von Willebrand syndrome associated to monoclonal gammopathy of undetermined significance.硼替佐米对一名患有意义未明的单克隆丙种球蛋白病相关获得性血管性血友病综合征患者的疗效。
Am J Hematol. 2010 May;85(5):396. doi: 10.1002/ajh.21692.
10
Bortezomib for the treatment of refractory Type-1 cryoglobulinaemia.硼替佐米用于治疗难治性1型冷球蛋白血症。
Br J Haematol. 2010 Jul;150(2):235-7. doi: 10.1111/j.1365-2141.2010.08184.x. Epub 2010 Mar 21.

引用本文的文献

1
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.特发性多中心Castleman病管理中未满足的临床需求：来自一个特设专家小组的基于共识的立场文件
Hemasphere. 2023 May 23;7(6):e891. doi: 10.1097/HS9.0000000000000891. eCollection 2023 Jun.
2
Castleman Disease.卡斯特曼病
Fed Pract. 2015 Aug;32(Suppl 7):41S-46S.
3
Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.特发性多中心 Castleman 病的新见解和治疗方法。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):318-325. doi: 10.1182/asheducation-2018.1.318.
4
Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.特发性多中心 Castleman 病的新见解和治疗方法。
Blood. 2018 Nov 29;132(22):2323-2330. doi: 10.1182/blood-2018-05-848671.
5
Biologic Agents in the Treatment of Multicentric Castleman Disease.生物制剂在多中心Castleman病治疗中的应用
Turk Thorac J. 2018 Oct;19(4):220-225. doi: 10.5152/TurkThoracJ.2018.18066. Epub 2018 Oct 1.
6
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.特发性多中心 Castleman 病的国际、循证共识治疗指南。
Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4.
7
Analysis of clinical characteristics and prognosis factors of 71 cases with HIV-negative Castleman's disease: hypoproteinemia is an unfavorable prognostic factor which should be treated appropriately.分析 71 例 HIV 阴性血管滤泡性淋巴结增生症患者的临床特征及预后因素：低蛋白血症是一个不利的预后因素，应适当治疗。
J Cancer Res Clin Oncol. 2018 Jul;144(7):1265-1277. doi: 10.1007/s00432-018-2647-z. Epub 2018 May 7.
8
TAFRO syndrome: current perspectives.TAFRO综合征：当前观点
J Blood Med. 2018 Jan 22;9:15-23. doi: 10.2147/JBM.S127822. eCollection 2018.
9
Multicentric Castleman's disease: a challenging diagnosis.多中心性 Castleman 病：一项具有挑战性的诊断。
Pathol Oncol Res. 2013 Jul;19(3):345-51. doi: 10.1007/s12253-013-9619-z. Epub 2013 Mar 21.
10
HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.人类疱疹病毒 8 相关多中心 Castleman 病在 HIV 阴性患者中的表现：一种孤儿病的新型疗法。
Oncologist. 2012;17(1):145-6; author reply 147-8. doi: 10.1634/theoncologist.2011-0226.